Christopher J. Borths

Author

Amgen (United States)ORCID

Also Known As

Borths, C.J., Borths, Christopher J., C. J. Borths, Christopher Borths, Christopher J. Borths

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)Pfizer (United States)AbbVie (United States)

About

Christopher J. Borths is an author at Amgen (United States) specializing in organic chemistry, natural sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	269
2	Natural Sciences	6	6	304
3	Biomolecular Engineering	6	6	1.8K
4	Engineering	5	5	1.8K
5	Biochemistry	5	5	176

Christopher J. Borths

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
New Strategies for Organic Catalysis: The First Highly Enantioselective Organocatalytic Diels−Alder Reaction Kateri A. Ahrendt, Christopher J. Borths, David W. C. MacMillan Journal of the American Chemical Society Chemical EngineeringOrganic CatalysisEngineeringNovel OrganocatalystsAltmetric Attention Score	2000	1.6K
A Highly Efficient Palladium/Copper Cocatalytic System for Direct Arylation of Heteroarenes: An Unexpected Effect of Cu(Xantphos)I Jinkun Huang, Johann Chan, Ying Chen, Journal of the American Chemical Society	2010	321
SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm Kevin J. Hamblett, Allison P. Jacob, Jesse L. Gurgel, Cancer Research Protein SecretionDrug TargetingNatural SciencesLysosomal TransporterImmunology	2015	128
Structural Characterization of a Monoclonal Antibody–Maytansinoid Immunoconjugate Quanzhou Luo, Hyo Helen Chung, Christopher J. Borths, Analytical Chemistry Immunocytochemical TechniqueImmunologyBioanalysisImmunochemistryAnalytical Chemistry	2015	57
Highly Selective Rhodium-Catalyzed Conjugate Addition Reactions of 4-Oxobutenamides Jamie L. Zigterman, Jacqueline C. S. Woo, Shawn D. Walker, The Journal of Organic Chemistry Arylboronic AcidsEngineeringBiochemistryNatural SciencesOrganic Chemistry	2007	53
Development of a Scalable Synthesis of a GPR40 Receptor Agonist Shawn D. Walker, Christopher J. Borths, Evan S. DiVirgilio, Organic Process Research & Development	2011	52
Practical Asymmetric Conjugate Alkynylation of Meldrum’s Acid-Derived Acceptors: Access to Chiral β-Alkynyl Acids Sheng Cui, Shawn D. Walker, Jacqueline C. S. Woo, Journal of the American Chemical Society	2009	50
Development of a general, enantioselective organocatalytic Mukaiyama–Michael reaction with α,β-unsaturated aldehydes Christopher J. Borths, Diane E. Carrera, David W. C. MacMillan Tetrahedron Novel OrganocatalystsEngineeringβ-Unsaturated AldehydesOrganic ChemistryCatalysis	2009	40
Development of a Commercial Manufacturing Process for Sotorasib, a First-in-Class KRAS<sup>G12C</sup> Inhibitor Liang Zhang, Daniel J. Griffin, Matthew G. Beaver, Organic Process Research & Development Combinatorial ChemistryMedicinal ChemistryPharmaceutical ChemistryBioorganic ChemistryAmg 510	2022	29
Nitrosamine Reactivity: A Survey of Reactions and Purge Processes Christopher J. Borths, Michael J. Burns, Timothy T. Curran, Organic Process Research & Development Pharmaceutical ScienceOrganic ChemistryPharmacotherapyChemistryChemical Processes	2021	26

Page 1